

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | urate metabolic process (GO:0046415) | 9.24156639 |
| 2 | drug transmembrane transport (GO:0006855) | 9.20223822 |
| 3 | organic cation transport (GO:0015695) | 8.33188387 |
| 4 | drug transport (GO:0015893) | 8.05603675 |
| 5 | phosphate ion transport (GO:0006817) | 7.31505274 |
| 6 | lysine metabolic process (GO:0006553) | 7.09582408 |
| 7 | lysine catabolic process (GO:0006554) | 7.09582408 |
| 8 | excretion (GO:0007588) | 6.83495327 |
| 9 | quaternary ammonium group transport (GO:0015697) | 6.28369807 |
| 10 | glyoxylate metabolic process (GO:0046487) | 6.08339677 |
| 11 | phosphate ion transmembrane transport (GO:0035435) | 5.97724100 |
| 12 | response to mercury ion (GO:0046689) | 5.73482653 |
| 13 | renal absorption (GO:0070293) | 5.66249308 |
| 14 | cysteine metabolic process (GO:0006534) | 5.65135942 |
| 15 | metanephric nephron tubule development (GO:0072234) | 5.51619968 |
| 16 | metanephric tubule development (GO:0072170) | 5.51619968 |
| 17 | toxin transport (GO:1901998) | 5.49779592 |
| 18 | glycoside metabolic process (GO:0016137) | 5.36959337 |
| 19 | drug catabolic process (GO:0042737) | 5.30348598 |
| 20 | homocysteine metabolic process (GO:0050667) | 5.24830755 |
| 21 | vitamin D metabolic process (GO:0042359) | 5.24646843 |
| 22 | metanephric nephron epithelium development (GO:0072243) | 5.17166803 |
| 23 | trivalent inorganic anion homeostasis (GO:0072506) | 5.08894255 |
| 24 | phosphate ion homeostasis (GO:0055062) | 5.08894255 |
| 25 | exogenous drug catabolic process (GO:0042738) | 5.08551560 |
| 26 | tricarboxylic acid metabolic process (GO:0072350) | 5.02551728 |
| 27 | metanephric epithelium development (GO:0072207) | 4.86601059 |
| 28 | short-chain fatty acid metabolic process (GO:0046459) | 4.76000734 |
| 29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.74776429 |
| 30 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.64251529 |
| 31 | aspartate family amino acid catabolic process (GO:0009068) | 4.36811357 |
| 32 | polyol transport (GO:0015791) | 4.36560575 |
| 33 | nephron tubule development (GO:0072080) | 4.32515998 |
| 34 | tryptophan metabolic process (GO:0006568) | 4.29447581 |
| 35 | branched-chain amino acid metabolic process (GO:0009081) | 4.28952776 |
| 36 | amino-acid betaine transport (GO:0015838) | 4.24205972 |
| 37 | carnitine transport (GO:0015879) | 4.24205972 |
| 38 | indole-containing compound catabolic process (GO:0042436) | 4.20256766 |
| 39 | indolalkylamine catabolic process (GO:0046218) | 4.20256766 |
| 40 | tryptophan catabolic process (GO:0006569) | 4.20256766 |
| 41 | vitamin catabolic process (GO:0009111) | 4.10849193 |
| 42 | fat-soluble vitamin catabolic process (GO:0042363) | 4.10849193 |
| 43 | renal tubule development (GO:0061326) | 4.08293434 |
| 44 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.02718179 |
| 45 | aromatic amino acid family catabolic process (GO:0009074) | 4.01020250 |
| 46 | fatty acid beta-oxidation (GO:0006635) | 3.92403139 |
| 47 | modified amino acid transport (GO:0072337) | 3.91626817 |
| 48 | valine metabolic process (GO:0006573) | 3.83110755 |
| 49 | response to magnesium ion (GO:0032026) | 3.78738582 |
| 50 | glutathione biosynthetic process (GO:0006750) | 3.76268320 |
| 51 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.74777318 |
| 52 | L-phenylalanine metabolic process (GO:0006558) | 3.74777318 |
| 53 | carnitine metabolic process (GO:0009437) | 3.66490592 |
| 54 | L-phenylalanine catabolic process (GO:0006559) | 3.63628000 |
| 55 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.63628000 |
| 56 | amino-acid betaine metabolic process (GO:0006577) | 3.61293576 |
| 57 | indole-containing compound metabolic process (GO:0042430) | 3.59918611 |
| 58 | daunorubicin metabolic process (GO:0044597) | 3.58906840 |
| 59 | polyketide metabolic process (GO:0030638) | 3.58906840 |
| 60 | doxorubicin metabolic process (GO:0044598) | 3.58906840 |
| 61 | nephron epithelium development (GO:0072009) | 3.57615493 |
| 62 | peptide catabolic process (GO:0043171) | 3.57568488 |
| 63 | branched-chain amino acid catabolic process (GO:0009083) | 3.53700868 |
| 64 | serine family amino acid metabolic process (GO:0009069) | 3.53476159 |
| 65 | fatty acid oxidation (GO:0019395) | 3.53225548 |
| 66 | lipid oxidation (GO:0034440) | 3.48842578 |
| 67 | aldehyde catabolic process (GO:0046185) | 3.48730140 |
| 68 | indolalkylamine metabolic process (GO:0006586) | 3.48496688 |
| 69 | cellular response to vitamin D (GO:0071305) | 3.47255764 |
| 70 | serine family amino acid catabolic process (GO:0009071) | 3.46997475 |
| 71 | proline metabolic process (GO:0006560) | 3.43862747 |
| 72 | 2-oxoglutarate metabolic process (GO:0006103) | 3.39807907 |
| 73 | NADH metabolic process (GO:0006734) | 3.35867298 |
| 74 | fructose metabolic process (GO:0006000) | 3.35084505 |
| 75 | peptide biosynthetic process (GO:0043043) | 3.34958002 |
| 76 | response to phenylpropanoid (GO:0080184) | 3.32124204 |
| 77 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.29970990 |
| 78 | nephron epithelium morphogenesis (GO:0072088) | 3.27704958 |
| 79 | nephron tubule morphogenesis (GO:0072078) | 3.27704958 |
| 80 | monocarboxylic acid catabolic process (GO:0072329) | 3.25518771 |
| 81 | polyol catabolic process (GO:0046174) | 3.22107329 |
| 82 | oligosaccharide catabolic process (GO:0009313) | 3.21883977 |
| 83 | cellular modified amino acid catabolic process (GO:0042219) | 3.20841731 |
| 84 | aromatic amino acid family metabolic process (GO:0009072) | 3.17250112 |
| 85 | fatty acid catabolic process (GO:0009062) | 3.16689127 |
| 86 | response to growth hormone (GO:0060416) | 3.16552401 |
| 87 | interferon-gamma production (GO:0032609) | 3.16125822 |
| 88 | sodium-independent organic anion transport (GO:0043252) | 3.12814466 |
| 89 | transepithelial transport (GO:0070633) | 3.07693563 |
| 90 | acetyl-CoA metabolic process (GO:0006084) | 3.04929149 |
| 91 | cellular ketone body metabolic process (GO:0046950) | 3.04873620 |
| 92 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.03992485 |
| 93 | glutathione metabolic process (GO:0006749) | 3.02381268 |
| 94 | sodium ion transport (GO:0006814) | 2.99693839 |
| 95 | sulfur compound transport (GO:0072348) | 2.94176156 |
| 96 | cytidine metabolic process (GO:0046087) | 2.93741079 |
| 97 | cytidine catabolic process (GO:0006216) | 2.93741079 |
| 98 | cytidine deamination (GO:0009972) | 2.93741079 |
| 99 | succinate metabolic process (GO:0006105) | 2.91700946 |
| 100 | aminoglycoside antibiotic metabolic process (GO:0030647) | 12.2993845 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 3.01495389 |
| 2 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.71192658 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.62053056 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.54347254 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.53743683 |
| 6 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.50611233 |
| 7 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.42586157 |
| 8 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.27177968 |
| 9 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.23219956 |
| 10 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.15769184 |
| 11 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.12396720 |
| 12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.02648705 |
| 13 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.96895556 |
| 14 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.93763624 |
| 15 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.91248832 |
| 16 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.87586915 |
| 17 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.86626073 |
| 18 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.84204486 |
| 19 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.75336556 |
| 20 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.72279110 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.70084884 |
| 22 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.70040347 |
| 23 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.65309120 |
| 24 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.64985453 |
| 25 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.62608146 |
| 26 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.62287148 |
| 27 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.60488722 |
| 28 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.59531880 |
| 29 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.56514435 |
| 30 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.52962071 |
| 31 | * VDR_22108803_ChIP-Seq_LS180_Human | 1.51662735 |
| 32 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.45585596 |
| 33 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.44907938 |
| 34 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.41871363 |
| 35 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.41014782 |
| 36 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.40515011 |
| 37 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.38683136 |
| 38 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.38334474 |
| 39 | * KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.36881547 |
| 40 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.36020774 |
| 41 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.35882883 |
| 42 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.35115167 |
| 43 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.33844318 |
| 44 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.30621709 |
| 45 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.30275764 |
| 46 | * ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.28106564 |
| 47 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.27590420 |
| 48 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.27271556 |
| 49 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.27127862 |
| 50 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.26615118 |
| 51 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.25858401 |
| 52 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.24608256 |
| 53 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.24545169 |
| 54 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.21790797 |
| 55 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.21773923 |
| 56 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.21222266 |
| 57 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.21187966 |
| 58 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.21139928 |
| 59 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.20873663 |
| 60 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.20824293 |
| 61 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.20824293 |
| 62 | * ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.19720803 |
| 63 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19604359 |
| 64 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.19297585 |
| 65 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.19178989 |
| 66 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.18410691 |
| 67 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.17757262 |
| 68 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.17325435 |
| 69 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.16559744 |
| 70 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16531544 |
| 71 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.16313826 |
| 72 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.15343148 |
| 73 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.15282580 |
| 74 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.14780414 |
| 75 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.14363230 |
| 76 | * CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.14220745 |
| 77 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.14174381 |
| 78 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.13648321 |
| 79 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.13290681 |
| 80 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.13120094 |
| 81 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.13084404 |
| 82 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.12168198 |
| 83 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.11899190 |
| 84 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.11000966 |
| 85 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.10330832 |
| 86 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.09936347 |
| 87 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.09479882 |
| 88 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.08601046 |
| 89 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.08199890 |
| 90 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.06307670 |
| 91 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.05894083 |
| 92 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05531806 |
| 93 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.05167888 |
| 94 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.04934804 |
| 95 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.04669324 |
| 96 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.04579808 |
| 97 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.03926251 |
| 98 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03567823 |
| 99 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.03563939 |
| 100 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 1.02813769 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004043_abnormal_pH_regulation | 6.54212457 |
| 2 | MP0005360_urolithiasis | 5.65758524 |
| 3 | MP0004019_abnormal_vitamin_homeostasis | 5.47318477 |
| 4 | MP0003195_calcinosis | 4.83582953 |
| 5 | MP0005332_abnormal_amino_acid | 4.32810320 |
| 6 | MP0009643_abnormal_urine_homeostasis | 3.94491892 |
| 7 | MP0001765_abnormal_ion_homeostasis | 3.86288959 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 3.83797512 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 3.47324619 |
| 10 | MP0005451_abnormal_body_composition | 3.39460521 |
| 11 | MP0001756_abnormal_urination | 3.16897727 |
| 12 | MP0005636_abnormal_mineral_homeostasis | 3.15245334 |
| 13 | MP0002136_abnormal_kidney_physiology | 3.09281110 |
| 14 | MP0003878_abnormal_ear_physiology | 2.62106435 |
| 15 | MP0005377_hearing/vestibular/ear_phenot | 2.62106435 |
| 16 | MP0008875_abnormal_xenobiotic_pharmacok | 2.11438534 |
| 17 | MP0001958_emphysema | 2.06853037 |
| 18 | MP0005084_abnormal_gallbladder_morpholo | 1.87559452 |
| 19 | MP0003186_abnormal_redox_activity | 1.87480873 |
| 20 | MP0004885_abnormal_endolymph | 1.85040356 |
| 21 | MP0005365_abnormal_bile_salt | 1.80654461 |
| 22 | MP0003724_increased_susceptibility_to | 1.80247822 |
| 23 | MP0003252_abnormal_bile_duct | 1.78912095 |
| 24 | MP0005085_abnormal_gallbladder_physiolo | 1.70740153 |
| 25 | MP0004147_increased_porphyrin_level | 1.65111940 |
| 26 | MP0005220_abnormal_exocrine_pancreas | 1.62037315 |
| 27 | MP0008961_abnormal_basal_metabolism | 1.59520078 |
| 28 | MP0000538_abnormal_urinary_bladder | 1.49140416 |
| 29 | MP0001984_abnormal_olfaction | 1.48975440 |
| 30 | MP0002876_abnormal_thyroid_physiology | 1.45951453 |
| 31 | MP0010234_abnormal_vibrissa_follicle | 1.45118457 |
| 32 | MP0002168_other_aberrant_phenotype | 1.29734393 |
| 33 | MP0010386_abnormal_urinary_bladder | 1.21237322 |
| 34 | MP0005058_abnormal_lysosome_morphology | 1.18736295 |
| 35 | MP0002796_impaired_skin_barrier | 1.16322118 |
| 36 | MP0002135_abnormal_kidney_morphology | 1.14086340 |
| 37 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.13674536 |
| 38 | MP0002928_abnormal_bile_duct | 1.10894528 |
| 39 | MP0009764_decreased_sensitivity_to | 1.08602228 |
| 40 | MP0000230_abnormal_systemic_arterial | 1.07436848 |
| 41 | MP0005501_abnormal_skin_physiology | 1.01388374 |
| 42 | MP0009379_abnormal_foot_pigmentation | 1.01009324 |
| 43 | MP0001188_hyperpigmentation | 1.00736496 |
| 44 | MP0009384_cardiac_valve_regurgitation | 1.00220655 |
| 45 | MP0005394_taste/olfaction_phenotype | 0.98886564 |
| 46 | MP0005499_abnormal_olfactory_system | 0.98886564 |
| 47 | MP0001666_abnormal_nutrient_absorption | 0.97416162 |
| 48 | MP0005408_hypopigmentation | 0.96644534 |
| 49 | MP0001764_abnormal_homeostasis | 0.88337433 |
| 50 | MP0006036_abnormal_mitochondrial_physio | 0.86273313 |
| 51 | MP0005535_abnormal_body_temperature | 0.85295209 |
| 52 | MP0005248_abnormal_Harderian_gland | 0.84206842 |
| 53 | MP0003868_abnormal_feces_composition | 0.82671166 |
| 54 | MP0005083_abnormal_biliary_tract | 0.80569427 |
| 55 | MP0004782_abnormal_surfactant_physiolog | 0.80546036 |
| 56 | MP0009672_abnormal_birth_weight | 0.79641304 |
| 57 | MP0002098_abnormal_vibrissa_morphology | 0.79536616 |
| 58 | MP0002896_abnormal_bone_mineralization | 0.78814977 |
| 59 | MP0005395_other_phenotype | 0.75338664 |
| 60 | MP0005319_abnormal_enzyme/_coenzyme | 0.74890740 |
| 61 | MP0003300_gastrointestinal_ulcer | 0.74597693 |
| 62 | MP0005646_abnormal_pituitary_gland | 0.74496305 |
| 63 | MP0003959_abnormal_lean_body | 0.73406022 |
| 64 | MP0003638_abnormal_response/metabolism_ | 0.72597092 |
| 65 | MP0003866_abnormal_defecation | 0.71667951 |
| 66 | MP0000490_abnormal_crypts_of | 0.63521418 |
| 67 | MP0004742_abnormal_vestibular_system | 0.63320743 |
| 68 | MP0005666_abnormal_adipose_tissue | 0.63189792 |
| 69 | MP0008789_abnormal_olfactory_epithelium | 0.61929193 |
| 70 | MP0008469_abnormal_protein_level | 0.61867075 |
| 71 | MP0009642_abnormal_blood_homeostasis | 0.61476270 |
| 72 | MP0002115_abnormal_skeleton_extremities | 0.61317711 |
| 73 | MP0005670_abnormal_white_adipose | 0.60263213 |
| 74 | MP0003941_abnormal_skin_development | 0.58602622 |
| 75 | MP0000678_abnormal_parathyroid_gland | 0.56982596 |
| 76 | MP0002998_abnormal_bone_remodeling | 0.56361064 |
| 77 | MP0000371_diluted_coat_color | 0.54779399 |
| 78 | MP0002118_abnormal_lipid_homeostasis | 0.50756234 |
| 79 | MP0005165_increased_susceptibility_to | 0.49137728 |
| 80 | MP0003795_abnormal_bone_structure | 0.46748301 |
| 81 | MP0001790_abnormal_immune_system | 0.45566257 |
| 82 | MP0005387_immune_system_phenotype | 0.45566257 |
| 83 | MP0002089_abnormal_postnatal_growth/wei | 0.44974276 |
| 84 | MP0001485_abnormal_pinna_reflex | 0.44548548 |
| 85 | MP0000163_abnormal_cartilage_morphology | 0.43598127 |
| 86 | MP0005334_abnormal_fat_pad | 0.43546299 |
| 87 | MP0000026_abnormal_inner_ear | 0.43525202 |
| 88 | MP0005174_abnormal_tail_pigmentation | 0.42262605 |
| 89 | MP0002069_abnormal_eating/drinking_beha | 0.41441102 |
| 90 | MP0001191_abnormal_skin_condition | 0.40678514 |
| 91 | MP0001879_abnormal_lymphatic_vessel | 0.40089201 |
| 92 | MP0001177_atelectasis | 0.38819114 |
| 93 | MP0003879_abnormal_hair_cell | 0.38403566 |
| 94 | MP0001963_abnormal_hearing_physiology | 0.38311156 |
| 95 | MP0010155_abnormal_intestine_physiology | 0.37999612 |
| 96 | MP0001845_abnormal_inflammatory_respons | 0.37823701 |
| 97 | MP0000534_abnormal_ureter_morphology | 0.37783746 |
| 98 | MP0002396_abnormal_hematopoietic_system | 0.36627637 |
| 99 | MP0001664_abnormal_digestion | 0.36153702 |
| 100 | MP0000383_abnormal_hair_follicle | 0.35150848 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Metabolic alkalosis (HP:0200114) | 8.07113269 |
| 2 | Increased circulating renin level (HP:0000848) | 7.87645847 |
| 3 | Hypokalemic alkalosis (HP:0001949) | 7.84333979 |
| 4 | Hypomagnesemia (HP:0002917) | 7.42853362 |
| 5 | Hyperactive renin-angiotensin system (HP:0000841) | 7.29679504 |
| 6 | Polyuria (HP:0000103) | 7.14933049 |
| 7 | Abnormal urine output (HP:0012590) | 6.65345837 |
| 8 | Abnormality of chloride homeostasis (HP:0011422) | 6.53811538 |
| 9 | Abnormality of magnesium homeostasis (HP:0004921) | 6.37552375 |
| 10 | Abnormality of renal excretion (HP:0011036) | 6.22714812 |
| 11 | Gout (HP:0001997) | 6.15305624 |
| 12 | Polydipsia (HP:0001959) | 5.80922613 |
| 13 | Abnormal drinking behavior (HP:0030082) | 5.80922613 |
| 14 | Tetany (HP:0001281) | 5.48058815 |
| 15 | Hyperaldosteronism (HP:0000859) | 5.39360874 |
| 16 | Proximal tubulopathy (HP:0000114) | 5.35510819 |
| 17 | Abnormality of renin-angiotensin system (HP:0000847) | 5.26448593 |
| 18 | Renal salt wasting (HP:0000127) | 5.08182832 |
| 19 | Alkalosis (HP:0001948) | 5.06906815 |
| 20 | Increased purine levels (HP:0004368) | 4.49752154 |
| 21 | Hyperuricemia (HP:0002149) | 4.49752154 |
| 22 | Generalized aminoaciduria (HP:0002909) | 4.29740917 |
| 23 | Hypokalemia (HP:0002900) | 4.16659612 |
| 24 | Hyperglycinuria (HP:0003108) | 4.03696551 |
| 25 | Hypercalciuria (HP:0002150) | 3.79775014 |
| 26 | Renal tubular acidosis (HP:0001947) | 3.76075420 |
| 27 | Abnormality of purine metabolism (HP:0004352) | 3.74909045 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.52328936 |
| 29 | Abnormality of potassium homeostasis (HP:0011042) | 3.35694994 |
| 30 | Dehydration (HP:0001944) | 3.24842362 |
| 31 | Abnormality of urine glucose concentration (HP:0011016) | 3.18972378 |
| 32 | Glycosuria (HP:0003076) | 3.18972378 |
| 33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.04937075 |
| 34 | Abnormality of glycine metabolism (HP:0010895) | 3.04937075 |
| 35 | Ketoacidosis (HP:0001993) | 3.01141425 |
| 36 | Hyperphosphaturia (HP:0003109) | 2.87607907 |
| 37 | Nephrocalcinosis (HP:0000121) | 2.82355919 |
| 38 | Abnormal urine phosphate concentration (HP:0012599) | 2.78890002 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 2.75172089 |
| 40 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.74249796 |
| 41 | Abnormality of sodium homeostasis (HP:0010931) | 2.71581287 |
| 42 | Hyponatremia (HP:0002902) | 2.68939158 |
| 43 | Delayed epiphyseal ossification (HP:0002663) | 2.56856093 |
| 44 | Enlarged kidneys (HP:0000105) | 2.52586072 |
| 45 | Widely patent fontanelles and sutures (HP:0004492) | 2.51498011 |
| 46 | Nephrolithiasis (HP:0000787) | 2.48465781 |
| 47 | Decreased circulating renin level (HP:0003351) | 2.43909006 |
| 48 | Ketosis (HP:0001946) | 2.41380452 |
| 49 | Tubulointerstitial fibrosis (HP:0005576) | 2.38183384 |
| 50 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.37848229 |
| 51 | Rickets (HP:0002748) | 2.37037827 |
| 52 | Hypophosphatemia (HP:0002148) | 2.36885697 |
| 53 | Tubular atrophy (HP:0000092) | 2.35818175 |
| 54 | Renal tubular dysfunction (HP:0000124) | 2.35343641 |
| 55 | Adrenal overactivity (HP:0002717) | 2.31935405 |
| 56 | Abnormality of renal resorption (HP:0011038) | 2.26804379 |
| 57 | Abnormality of the renal cortex (HP:0011035) | 2.24739540 |
| 58 | Vacuolated lymphocytes (HP:0001922) | 2.23705839 |
| 59 | Vomiting (HP:0002013) | 2.22850683 |
| 60 | Hyperglycinemia (HP:0002154) | 2.16554057 |
| 61 | Abnormality of proline metabolism (HP:0010907) | 2.12014572 |
| 62 | Hydroxyprolinuria (HP:0003080) | 2.12014572 |
| 63 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.11130816 |
| 64 | Dicarboxylic aciduria (HP:0003215) | 2.10230972 |
| 65 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.10230972 |
| 66 | Neonatal onset (HP:0003623) | 2.09864038 |
| 67 | Vascular calcification (HP:0004934) | 2.05430066 |
| 68 | Metabolic acidosis (HP:0001942) | 2.00999246 |
| 69 | Renal cortical cysts (HP:0000803) | 1.97554980 |
| 70 | Facial shape deformation (HP:0011334) | 1.84954799 |
| 71 | Potter facies (HP:0002009) | 1.84954799 |
| 72 | Hyperammonemia (HP:0001987) | 1.77098332 |
| 73 | Abnormality of Sharpey fibers (HP:0100685) | 1.75604675 |
| 74 | Cardiovascular calcification (HP:0011915) | 1.75574643 |
| 75 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.75378369 |
| 76 | Hypophosphatemic rickets (HP:0004912) | 1.73967118 |
| 77 | Metaphyseal cupping (HP:0003021) | 1.72454645 |
| 78 | Chondrocalcinosis (HP:0000934) | 1.72210341 |
| 79 | Delayed CNS myelination (HP:0002188) | 1.71251883 |
| 80 | Hypothermia (HP:0002045) | 1.71140999 |
| 81 | Tubulointerstitial abnormality (HP:0001969) | 1.70606982 |
| 82 | Metaphyseal irregularity (HP:0003025) | 1.67831774 |
| 83 | Bicornuate uterus (HP:0000813) | 1.67770827 |
| 84 | Thin bony cortex (HP:0002753) | 1.67397355 |
| 85 | Metaphyseal dysplasia (HP:0100255) | 1.63041487 |
| 86 | Lethargy (HP:0001254) | 1.62715882 |
| 87 | Hypotension (HP:0002615) | 1.62646836 |
| 88 | Methylmalonic aciduria (HP:0012120) | 1.60860823 |
| 89 | Generalized muscle weakness (HP:0003324) | 1.59067364 |
| 90 | Tachypnea (HP:0002789) | 1.54677403 |
| 91 | Malnutrition (HP:0004395) | 1.54264017 |
| 92 | Enlarged epiphyses (HP:0010580) | 1.53522870 |
| 93 | Confusion (HP:0001289) | 1.53471584 |
| 94 | Nausea (HP:0002018) | 1.52152871 |
| 95 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.51904687 |
| 96 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.50685534 |
| 97 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.50685534 |
| 98 | Glomerulosclerosis (HP:0000096) | 1.48897267 |
| 99 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.48808201 |
| 100 | Abnormality of the costochondral junction (HP:0000919) | 1.47905801 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 7.80101286 |
| 2 | WNK3 | 7.66189134 |
| 3 | OXSR1 | 7.05803658 |
| 4 | STK39 | 3.66628875 |
| 5 | SGK223 | 2.23262588 |
| 6 | SGK494 | 2.23262588 |
| 7 | TXK | 1.99052687 |
| 8 | SRPK1 | 1.98523841 |
| 9 | STK38L | 1.96274164 |
| 10 | SGK2 | 1.92229280 |
| 11 | MAP2K6 | 1.64927346 |
| 12 | BCKDK | 1.62038712 |
| 13 | SGK3 | 1.48752630 |
| 14 | SIK3 | 1.34910053 |
| 15 | DAPK2 | 1.32020594 |
| 16 | IRAK3 | 1.27794776 |
| 17 | MAP3K14 | 1.26015262 |
| 18 | WNK1 | 1.25500218 |
| 19 | MST4 | 1.18023197 |
| 20 | MYLK | 1.13275324 |
| 21 | GRK1 | 1.12892546 |
| 22 | NEK6 | 1.12483141 |
| 23 | PDK2 | 1.06141757 |
| 24 | MAP3K12 | 1.01169560 |
| 25 | MST1R | 0.95098311 |
| 26 | PDK3 | 0.87935565 |
| 27 | PDK4 | 0.87935565 |
| 28 | STK11 | 0.86299121 |
| 29 | PAK4 | 0.84575150 |
| 30 | PIK3CA | 0.82642739 |
| 31 | ACVR1B | 0.81298445 |
| 32 | IRAK2 | 0.74608697 |
| 33 | PINK1 | 0.71112998 |
| 34 | CASK | 0.69461369 |
| 35 | EIF2AK2 | 0.67839351 |
| 36 | STK38 | 0.66945727 |
| 37 | MAP3K7 | 0.62645296 |
| 38 | BMPR2 | 0.60656644 |
| 39 | RIPK4 | 0.60352345 |
| 40 | GSK3A | 0.58525380 |
| 41 | ADRBK2 | 0.58524997 |
| 42 | BCR | 0.58508726 |
| 43 | SIK1 | 0.58507094 |
| 44 | ZAK | 0.58384682 |
| 45 | PRKCI | 0.57971407 |
| 46 | SGK1 | 0.56741886 |
| 47 | IRAK1 | 0.56703044 |
| 48 | INSRR | 0.55285516 |
| 49 | MAP3K2 | 0.53743123 |
| 50 | FGFR4 | 0.52236395 |
| 51 | TRPM7 | 0.46365757 |
| 52 | ERBB4 | 0.45130247 |
| 53 | NEK9 | 0.44124665 |
| 54 | YES1 | 0.43589026 |
| 55 | EPHA4 | 0.42869616 |
| 56 | PRKCZ | 0.41172891 |
| 57 | IRAK4 | 0.40717294 |
| 58 | PRKCD | 0.39785175 |
| 59 | MAP4K1 | 0.37235855 |
| 60 | CAMKK2 | 0.36794365 |
| 61 | NEK1 | 0.36223227 |
| 62 | ERBB3 | 0.34278312 |
| 63 | PIK3CG | 0.33910777 |
| 64 | CAMK4 | 0.33311235 |
| 65 | MAP2K3 | 0.32511467 |
| 66 | PRKCG | 0.31516790 |
| 67 | TLK1 | 0.29869322 |
| 68 | DYRK1B | 0.29340924 |
| 69 | CAMK1 | 0.29232820 |
| 70 | IKBKE | 0.28310790 |
| 71 | PKN1 | 0.27105366 |
| 72 | PTK2 | 0.26889036 |
| 73 | NTRK3 | 0.26751726 |
| 74 | MAPK11 | 0.26656444 |
| 75 | MAP2K7 | 0.26467129 |
| 76 | PTK6 | 0.25961000 |
| 77 | PRKACA | 0.25818345 |
| 78 | OBSCN | 0.25785726 |
| 79 | MAP3K3 | 0.25765615 |
| 80 | PAK3 | 0.24577787 |
| 81 | PRKCA | 0.23152236 |
| 82 | CSNK1A1 | 0.22860278 |
| 83 | PRKCQ | 0.22591193 |
| 84 | NME1 | 0.22349109 |
| 85 | PRKCE | 0.21448121 |
| 86 | TNK2 | 0.19570239 |
| 87 | TIE1 | 0.19474897 |
| 88 | PRKAA1 | 0.18861401 |
| 89 | PRPF4B | 0.18798931 |
| 90 | MAPK12 | 0.18784073 |
| 91 | ABL2 | 0.17589369 |
| 92 | LYN | 0.16603420 |
| 93 | CHUK | 0.16450079 |
| 94 | TYK2 | 0.15819970 |
| 95 | FRK | 0.15562639 |
| 96 | GRK6 | 0.14934417 |
| 97 | PRKACG | 0.14684165 |
| 98 | MAPK4 | 0.13932354 |
| 99 | FER | 0.12312108 |
| 100 | EIF2AK1 | 0.12119706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.89014755 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.62819941 |
| 3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.30805831 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.22898931 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.17518816 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.11500726 |
| 7 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.00509839 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.86295726 |
| 9 | Peroxisome_Homo sapiens_hsa04146 | 2.82242003 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.77648812 |
| 11 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.56002192 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.51303612 |
| 13 | * Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.47765289 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.41762818 |
| 15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.28963586 |
| 16 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.15033348 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.13151303 |
| 18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.07065839 |
| 19 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.02863970 |
| 20 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.81681833 |
| 21 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.73792343 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.66623596 |
| 23 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.64313592 |
| 24 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.60258286 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.52122371 |
| 26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.48691296 |
| 27 | Mineral absorption_Homo sapiens_hsa04978 | 1.48163869 |
| 28 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.43536976 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.38442595 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.37532129 |
| 31 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.37224168 |
| 32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30946358 |
| 33 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.28265780 |
| 34 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.26754045 |
| 35 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.25504525 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.22936172 |
| 37 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.22387171 |
| 38 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.22170430 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.20233974 |
| 40 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.19722560 |
| 41 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.05298512 |
| 42 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.04972520 |
| 43 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.99421629 |
| 44 | Histidine metabolism_Homo sapiens_hsa00340 | 0.98405607 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.96021484 |
| 46 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.93116159 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.91060237 |
| 48 | Lysine degradation_Homo sapiens_hsa00310 | 0.87415706 |
| 49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.82195164 |
| 50 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82054867 |
| 51 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.76533893 |
| 52 | Retinol metabolism_Homo sapiens_hsa00830 | 0.74999958 |
| 53 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.74261669 |
| 54 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.73234191 |
| 55 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.66207789 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66089563 |
| 57 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.65198984 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.64318944 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.59336425 |
| 60 | Parkinsons disease_Homo sapiens_hsa05012 | 0.59188147 |
| 61 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.58570422 |
| 62 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.58166106 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.53851194 |
| 64 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.51199708 |
| 65 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.50589825 |
| 66 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.49718200 |
| 67 | Lysosome_Homo sapiens_hsa04142 | 0.46741110 |
| 68 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.46712346 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 0.42825061 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42728035 |
| 71 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.42628198 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40361351 |
| 73 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.37738271 |
| 74 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.34569792 |
| 75 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34354635 |
| 76 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.34348780 |
| 77 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.29897800 |
| 78 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.26736120 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.25486785 |
| 80 | * Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.23303687 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.20678775 |
| 82 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.20502352 |
| 83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.20390145 |
| 84 | Alzheimers disease_Homo sapiens_hsa05010 | 0.19713724 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.19025280 |
| 86 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.18391403 |
| 87 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.18350013 |
| 88 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.17396156 |
| 89 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.15834704 |
| 90 | Hepatitis C_Homo sapiens_hsa05160 | 0.15229756 |
| 91 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.14982429 |
| 92 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.13790497 |
| 93 | Sulfur relay system_Homo sapiens_hsa04122 | 0.12040927 |
| 94 | * Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.09853017 |
| 95 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.08713522 |
| 96 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.06285807 |
| 97 | Huntingtons disease_Homo sapiens_hsa05016 | 0.04214618 |
| 98 | Mismatch repair_Homo sapiens_hsa03430 | 0.03989339 |
| 99 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.03218234 |
| 100 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.01743442 |

